Tanog, Merlina A.

HRN: 27-11-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2025
08/14/2025
IV
500mg
Q8h
Inguinal Hernia, Right
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: